Skip to main content
Top
Published in: Sleep and Breathing 3/2021

01-09-2021 | Sleep Apnea | Sleep Breathing Physiology and Disorders • Review

Effect of continuous positive airway pressure on gastroesophageal reflux in patients with obstructive sleep apnea: a meta-analysis

Authors: Cheng Li, Zeng-hong Wu, Xiao-ling Pan, Kun Yuan

Published in: Sleep and Breathing | Issue 3/2021

Login to get access

Abstract

Purpose

Gastroesophageal reflux disease (GERD) often occurs in patients with obstructive sleep apnea (OSA). Although continuous positive airway pressure (CPAP) is considered to be the preferred treatment for OSA, the effect of CPAP therapy on reflux events remains controversial. In this study, we utilized meta-analysis to investigate whether or not CPAP treatment reduces the incidence of reflux.

Methods

Two independent reviewers obtained the data sources from the database of PubMed, Elsevier, Cochrane library, and CNKI using search terms, and then filtered the target articles based on the inclusion and exclusion criteria. RevMan (version 5.3) and STATA (version 12.0) were used for data synthesis. The effect of CPAP treatment on GERD was studied by calculating the weighted mean difference (WMD) and standard deviation (SD) before and after CPAP treatment.

Results

Ten studies involving a total of 272 participants were included in this study. The results showed that the total of WMD before and after CPAP was − 17.68 (95% CI − 30.67 to − 4.69) for percentage time pH < 4, − 24.66 (95% CI − 36.15 to − 13.18) for the longest reflux duration, − 27.53 (95% CI − 49.53 to − 5.52) for number of reflux events, − 49.76 (95% CI − 60.18 to − 39.35) for DeMeester score, − 1.85 (95% CI − 3.00 to − 0.71) for reflux diseases questionnaire (RDQ) score, and − 8.95 (95% CI − 16.00 to − 1.89) for reflux symptom index (RSI). The subgroup analysis demonstrated that the improvement of reflux symptoms was more obvious with the extension of treatment time.

Conclusions

This meta-analysis showed that CPAP treatment significantly reduces the incidence of reflux events in patients with OSA.
Appendix
Available only for authorised users
Literature
23.
go back to reference Zheng S (2012) The Second Xiangya Hospital of Central South University. Observation of the efficacy of nasal continuous positive airway pressure combined with anti-reflux drugs in the treatment of elderly patients with OSAHS and GERD [J]. The 1st China Beijing China Geriatrics and Geriatric Health Industry Conference (in Chinese) Zheng S (2012) The Second Xiangya Hospital of Central South University. Observation of the efficacy of nasal continuous positive airway pressure combined with anti-reflux drugs in the treatment of elderly patients with OSAHS and GERD [J]. The 1st China Beijing China Geriatrics and Geriatric Health Industry Conference (in Chinese)
25.
go back to reference Watson NF, Mystkowski SK (2008) Aerophagia and gastroesophageal reflux disease in patients using continuous positive airway pressure: a preliminary observation. [J]. J Clin Sleep Med 4:434–438CrossRefPubMedPubMedCentral Watson NF, Mystkowski SK (2008) Aerophagia and gastroesophageal reflux disease in patients using continuous positive airway pressure: a preliminary observation. [J]. J Clin Sleep Med 4:434–438CrossRefPubMedPubMedCentral
Metadata
Title
Effect of continuous positive airway pressure on gastroesophageal reflux in patients with obstructive sleep apnea: a meta-analysis
Authors
Cheng Li
Zeng-hong Wu
Xiao-ling Pan
Kun Yuan
Publication date
01-09-2021
Publisher
Springer International Publishing
Published in
Sleep and Breathing / Issue 3/2021
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-020-02224-9

Other articles of this Issue 3/2021

Sleep and Breathing 3/2021 Go to the issue

Sleep Breathing Physiology and Disorders • Original Article

The effects of intermittent hypoxia on human nasal mucosa

Sleep Breathing Physiology and Disorders • Original Article

Obstructive sleep apnea syndrome as a potential cause of sexual dysfunction in women

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.